History
2021
2020
2019
2018
2017
2015
2010
- Completion of Phase 1 Study of TAH3311 Anticoagulant Oral Film in Canada
- Patent Allowed
- US: TAH6601; China: TAH4411; Taiwan: TAH3301
2020
- Patent Allowed
- China TAH9901; Australia and New Zealand: TAH4411
2019
- Out-licensed TAH9922 Atomoxetine Oral Liq for US market
- Launched TAH4411 Ondansetron OD Film in Japan
- Patent Allowed
- US: TAH990
2018
- Japanese Approval for TAH4411 Ondansetron OD Film
- The first Ondansetron oral film approval in Japan.
- Patent Allowed
- US: TAH9901, TAH9922; Taiwan: TAH9922
2017
- Patent Allowed
- US: TAH9901, TAH9922
2015
- Completion of TAH4411 Ondansetron OD Film Clinical Study
2010
- TAHO was founded in Taipei, Taiwan